The hypertrophic and keloid scar treatment market in Europe is expected to grow from US$ 1,376.88 million in 2020 to US$ 2,705.59 million by 2027; it is estimated to grow at a CAGR of 10.1% from 2020 to 2027.
The UK, Germany, and France are major economies in Europe. Growing cases of injuries is the major factor driving the growth of the Europe hypertrophic and keloid scar treatment market. Injuries and their extension deep into the dermis are the major cause of hypertrophic and keloids scars. Injuries can be further classified as scratches, burns, cuts, gashes, sutures, surgical incisions, and so on. The prevalence rate of injuries ultimately converting to a keloid or hypertrophic scars is 5–15%. In addition, skin conditions such as acne and dark pigmentation also lead to hypertrophic and keloid scar development. The cases of different types of injuries are commonly seen among all age groups. Acne, sports injuries, and road accidents are more common among youngsters. Acne is also a common problem among middle-aged people, irrespective of their gender. The hormonal imbalance among people leads to acne, which might leave severe scars on skin. Acne is estimated to be affecting ~10% of the total global population. According to the WHO data published in February 2020, road accident-led injuries are the leading cause of death among young adults aged 5–29. ~1.35 million fatalities are registered per year due to road accidents. However, the rate of severe injuries by road accidents is also rising. Therefore, the increasing number of accidents is indirectly leading to the rising demand for hypertrophic and keloid scar treatments, which is further anticipated to drive the market in Europe.
Spain, Italy, Germany, France, and the UK are the most affected countries in Europe, owing to the increasing number of COVID-19 cases and deaths. As per the Worldometer, in Spain, Italy, Germany, France, and the UK, the number of cases is 2.25 million, 2.37 million, 2 million, 95 million, 3.36 million, respectively. The number of deaths in these countries is also high. As per the news article, in Italy, due to the COVID-19 emergency, access for thousands of cancer patients in need of chemotherapy, scans, transplants, and surgery has become difficult. There is several issued guidance from national and international organizations trying to help cope with suspected or verified COVID-19 patients. Besides, Germany has prolonged its pandemic prohibitions, including closing schools and shops, until mid-February due to fears that new COVID-19 mutations could cause a further increase in cases. In addition to extending the closing of restaurants, shops, and schools until February 14, Merkel and the governors of Germany's 16 states decided to enable citizens to wear more functional FFP2 or KN95 masks on public transport and supermarkets. Employers would now be ordered to encourage workers to work from home, wherever possible, to prevent office-driven infections. Hypertrophic and keloid scar treatment patients are considered less sensitive from COVID-19 than the general population. Europe has long been within an area of dynamic development in dermatology procedures, adapting to different cultures, traditions, and surgical and medical philosophies. In recent times, these changes have been even more significant and rapid.
- This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.
Europe Hypertrophic and Keloid Scar Treatment Market Segmentation
Europe Hypertrophic and Keloid Scar Treatment Market – By Scar Type
- Hypertrophic
- Keloid
Europe Hypertrophic and Keloid Scar Treatment Market – By Product Type
- Injectables
- Topical
- Gels
- Silicone Sheets
- Creams
- Other
- Laser
- CO2
- Pulse-Dyed
- Other
- Other
Europe Hypertrophic and Keloid Scar Treatment Market – By End User
- Hospitals
- Clinics
- Homecare
Europe Hypertrophic and Keloid Scar Treatment Market, by Country
- Germany
- UK
- France
- Italy
- Spain
- Rest of Europe
Europe Hypertrophic and Keloid Scar Treatment Market-Companies Mentioned
- Alliance Pharma PLC
- HRA Pharma
- Mölnlycke Health Care AB.
- Newmedical Technology Inc.
- Perrigo Company plc
- Lumenis
- Smith & Nephew
- Sonoma Pharmaceuticals, Inc
- Suneva Medical
Europe Hypertrophic and Keloid Scar Treatment Report Scope
Report Attribute | Details |
---|---|
Market size in 2020 | US$ 1,376.88 Million |
Market Size by 2027 | US$ 2,705.59 Million |
Global CAGR (2020 - 2027) | 10.1% |
Historical Data | 2018-2019 |
Forecast period | 2021-2027 |
Segments Covered |
By Scar Type
|
Regions and Countries Covered | Europe
|
Market leaders and key company profiles |
- Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
- PEST and SWOT Analysis
- Market Size Value / Volume - Global, Regional, Country
- Industry and Competitive Landscape
- Excel Dataset
Testimonials

I wish to appreciate your support and the professionalism you displayed in the course of attending to my request for information regarding to infectious disease IVD market in Nigeria. I appreciate your patience, your guidance, and the fact that you were willing to offer a discount, which eventually made it possible for us to close a deal. I look forward to engaging The Insight Partners in the future, all thanks to the impression you have created in me as a result of this first encounter.
DR CHIJIOKE ONYIA, MANAGING DIRECTOR, PineCrest Healthcare Ltd.
The Insight Partners delivered insightful, well-structured market research with strong domain expertise. Their team was professional and responsive throughout. The user-friendly website made accessing industry reports seamless. We highly recommend them for reliable, high-quality research services
Yukihiko Adachi CEO, Deep Blue, LLC.Reason to Buy
- Informed Decision-Making
- Understanding Market Dynamics
- Competitive Analysis
- Customer Insights
- Market Forecasts
- Risk Mitigation
- Strategic Planning
- Investment Justification
- Identifying Emerging Markets
- Enhancing Marketing Strategies
- Boosting Operational Efficiency
- Tracking Industry Innovations
- Aligning with Regulatory Trends
Yes! We provide a free sample of the report, which includes Report Scope (Table of Contents), report structure, and selected insights to help you assess the value of the full report. Please click on the "Download Sample" button or contact us to receive your copy.
Absolutely — analyst assistance is part of the package. You can connect with our analyst post-purchase to clarify report insights, methodology or discuss how the findings apply to your business needs.
Once your order is successfully placed, you will receive a confirmation email along with your invoice.
• For published reports: You’ll receive access to the report within 4–6 working hours via a secured email sent to your email.
• For upcoming reports: Your order will be recorded as a pre-booking. Our team will share the estimated release date and keep you informed of any updates. As soon as the report is published, it will be delivered to your registered email.
We offer customization options to align the report with your specific objectives. Whether you need deeper insights into a particular region, industry segment, competitor analysis, or data cut, our research team can tailor the report accordingly. Please share your requirements with us, and we’ll be happy to provide a customized proposal or scope.
The report is available in either PDF format or as an Excel dataset, depending on the license you choose.
The PDF version provides the full analysis and visuals in a ready-to-read format. The Excel dataset includes all underlying data tables for easy manipulation and further analysis.
Please review the license options at checkout or contact us to confirm which formats are included with your purchase.
Our payment process is fully secure and PCI-DSS compliant.
We use trusted and encrypted payment gateways to ensure that all transactions are protected with industry-standard SSL encryption. Your payment details are never stored on our servers and are handled securely by certified third-party processors.
You can make your purchase with confidence, knowing your personal and financial information is safe with us.
Yes, we do offer special pricing for bulk purchases.
If you're interested in purchasing multiple reports, we’re happy to provide a customized bundle offer or volume-based discount tailored to your needs. Please contact our sales team with the list of reports you’re considering, and we’ll share a personalized quote.
Yes, absolutely.
Our team is available to help you make an informed decision. Whether you have questions about the report’s scope, methodology, customization options, or which license suits you best, we’re here to assist. Please reach out to us at sales@theinsightpartners.com, and one of our representatives will get in touch promptly.
Yes, a billing invoice will be automatically generated and sent to your registered email upon successful completion of your purchase.
If you need the invoice in a specific format or require additional details (such as company name, GST, or VAT information), feel free to contact us, and we’ll be happy to assist.
Yes, certainly.
If you encounter any difficulties accessing or receiving your report, our support team is ready to assist you. Simply reach out to us via email or live chat with your order information, and we’ll ensure the issue is resolved quickly so you can access your report without interruption.















- Alliance Pharma PLC
- HRA Pharma
- Mölnlycke Health Care AB.
- Newmedical Technology Inc.
- Perrigo Company plc
- Lumenis
- Smith & Nephew
- Sonoma Pharmaceuticals, Inc
- Suneva Medical


